Editorial

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

Canada Moves. Alzheimer’s Patients Still Wait.

Beyond GLP-1s: Lilly is spending billions on a more targeted future in neuroscience

Prostate Cancer Treatment Is Creating a Metabolic Bill

Breastfeeding Enters the MOGAD Conversation

Hodgkin Lymphoma Survivors Are Still Paying for Cure

Sanfilippo’s Approval Path Is Being Built Before Approval

Pertussis Rose. The Definition Amplified It.

More than half had silent atherosclerosis. Standard risk scores missed many of them
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
